Novabay Pharmaceuticals (NBY) Stock Price, Quote & News

Company Profile

NovaBay Pharmaceuticals, Inc. does not have significant operations. Previously, the company was engaged in the development and sale of eyecare, wound care, and skin care products in the United States and internationally. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 510 899 8800

Fax: 510 474 1577

Website: novabay.com

Address:

2000 Powell Street, Suite 1150, eleventh floor, Emeryville, United States

DonCorleone77 Oct. 3 at 9:58 PM

$NBY NovaBay files $200M mixed securities shelf

0 · Reply

Retail_Warrior Oct. 3 at 9:10 PM

$NBY This is going to end badly for the market makers.

0 · Reply

sh4dowtrader Oct. 3 at 8:06 PM

$NBY continues

0 · Reply

Robin_x Oct. 3 at 7:03 PM

$NBY bought more!

0 · Reply

Robin_x Oct. 3 at 3:35 PM

$NBY Perfectly buying opportunity!

0 · Reply

Natalia10 Oct. 3 at 3:31 PM

$NBY is this one going anywhere?

0 · Reply

CashTopic Oct. 3 at 2:10 PM

$NBY I raked in the dividend here. But, what I am more interested in now, are the shorts coming back in to drag the SP down?

0 · Reply

HouseOfTheDragons Oct. 3 at 8:22 AM

Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $CJET $ELPW $NBY $LVTX xxx

0 · Reply

Super_Kelsey Oct. 3 at 2:12 AM

Looks like all eyes will be on ticker GIPR tomorrow. GIPR is the type of tickers market sending up on a massive 200-300%+ rally. GIPR ✅Partnerships = increase revenues ✅Go private = They are undervalued currently compared to peers and revenues ✅Joint venture = would increase share price tremendously ✅Sale of the company = they would get probably 4x-5x minimum their yearly revenues. .. $APDN $NBY $APLT $VERI

0 · Reply

ATLDawg Oct. 2 at 10:46 PM

$BQ $CION $NBY $QCLS $SPHL @Whiskey1679 What’s going on with $NBY Just got divi recently and held. Just hit upper 1.70’s in AH.

0 · Reply

NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

Aug 26, 2025, 4:05 PM EDT - 5 weeks ago

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

Aug 19, 2025, 5:25 PM EDT - 6 weeks ago

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Mar 7, 2025, 6:50 AM EST - 7 months ago

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Jan 23, 2025, 8:00 AM EST - 9 months ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Dec 19, 2024, 6:50 AM EST - 10 months ago

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Dec 9, 2024, 6:50 AM EST - 10 months ago

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Nov 22, 2024, 4:05 PM EST - 11 months ago

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Nov 15, 2024, 8:00 AM EST - 11 months ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Nov 7, 2024, 4:05 PM EST - 11 months ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:05 PM EST - 11 months ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Oct 29, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

Sep 20, 2024, 8:30 AM EDT - 1 year ago

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Sep 20, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Aug 13, 2024, 11:29 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Jul 30, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Jul 29, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

Jul 26, 2024, 8:30 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Jul 16, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

Jul 11, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jun 28, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Jun 7, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

May 29, 2024, 5:22 PM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

May 13, 2024, 8:30 AM EDT - 1 year ago

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

May 11, 2024, 1:59 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

May 3, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024

Apr 22, 2024, 6:57 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

Apr 19, 2024, 6:00 PM EDT - 1 year ago

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Apr 17, 2024, 6:59 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Mar 26, 2024, 6:43 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Mar 25, 2024, 6:38 PM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Mar 14, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

Jan 30, 2024, 9:00 AM EST - 1 year ago

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

Jan 9, 2024, 9:15 AM EST - 1 year ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

SNOA

Dec 6, 2023, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

Nov 9, 2023, 11:43 PM EST - 2 years ago

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 2 years ago

NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

Oct 11, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs

Oct 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

Sep 14, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft

Sep 11, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

Aug 12, 2023, 2:40 PM EDT - 2 years ago

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2023 Earnings Call Transcript

DonCorleone77 Oct. 3 at 9:58 PM

$NBY NovaBay files $200M mixed securities shelf

0 · Reply

Retail_Warrior Oct. 3 at 9:10 PM

$NBY This is going to end badly for the market makers.

0 · Reply

sh4dowtrader Oct. 3 at 8:06 PM

$NBY continues

0 · Reply

Robin_x Oct. 3 at 7:03 PM

$NBY bought more!

0 · Reply

Robin_x Oct. 3 at 3:35 PM

$NBY Perfectly buying opportunity!

0 · Reply

Natalia10 Oct. 3 at 3:31 PM

$NBY is this one going anywhere?

0 · Reply

CashTopic Oct. 3 at 2:10 PM

$NBY I raked in the dividend here. But, what I am more interested in now, are the shorts coming back in to drag the SP down?

0 · Reply

HouseOfTheDragons Oct. 3 at 8:22 AM

0 · Reply

Super_Kelsey Oct. 3 at 2:12 AM

0 · Reply

ATLDawg Oct. 2 at 10:46 PM

$BQ $CION $NBY $QCLS $SPHL @Whiskey1679 What’s going on with $NBY Just got divi recently and held. Just hit upper 1.70’s in AH.

0 · Reply

Whiskey1679 Oct. 2 at 10:19 PM

I hope everyone killed it today! See my Pinned time stamp Post for some of Today's WINNERS!!! Whiskey's Picks out tomorrow approx. 6:15 am PDT ***Have a great night folks!!!*** AH Gainers: $BQ $SPHL $NBY $QCLS $CION

3 · Reply

Robin_x Oct. 2 at 6:15 PM

$NBY still going up!

0 · Reply

ATLDawg Oct. 2 at 6:06 PM

$NBY I’m not going to post in case I jinx it😂

1 · Reply

Robin_x Oct. 2 at 5:54 PM

$NBY Damnnn

0 · Reply

Bazzzigar Oct. 2 at 4:00 PM

$NBY AEMD

0 · Reply

typevoid Oct. 2 at 3:45 PM

$NBY Just got message from ibkr about divis processing

0 · Reply

Robin_x Oct. 2 at 1:24 PM

$NBY

0 · Reply

Robin_x Oct. 2 at 12:27 PM

$NBY I’ve got dividend money today 👍

0 · Reply

jtsxlr Oct. 1 at 4:22 PM

$NBY Yayyyy, it's moving. $DVLT , $GPUS , $PSTV

0 · Reply

jtsxlr Oct. 1 at 3:43 PM

$NBY We need some volume for sure.

0 · Reply

jtsxlr Oct. 1 at 3:42 PM

$NBY For those of you wondering where your divy is ... if you sold before the 29th you lose out, you had to hold through the dates posted in this situation (Sept 15th - Sept 29th). I held mine and received the dividend on the 30th ... now that the stock dropped by that amount I'm adding, what's keeping me in this one is the fact that David Lazar has a 19.99% stake in the company as of Aug 29th. Good times ahead IMO. GLTA.

0 · Reply

JKpeeps Oct. 1 at 3:09 PM

$NBY

0 · Reply

Market Cap	9.19M
Revenue (ttm)	9.78M
Net Income (ttm)	-7.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-73.82%
Debt to Equity Ratio	0.00

Volume	632,000
Avg Vol	8,864,388
Day's Range	N/A - N/A
Shares Out	6.01M
Stochastic %K	11%
Beta	0.62
Analysts	Sell
Price Target	$0.85